Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
Anticipated barriers and facilitators for implementing smart inhalers in asthma medication adherence management
van de Hei, S. J., Stoker, N., Flokstra-de Blok, B. M. J., Poot, C. C., Meijer, E., Postma, M. J., Chavannes, N. H., Kocks, J. W. H. & van Boven, J. F. M., 20-mei-2023, In: npj Primary Care Respiratory Medicine. 33, 10 blz., 22.Onderzoeksoutput › Academic › peer review
Open AccessBestand1 Downloads (Pure) -
Clinical and economic burden of drug-susceptible tuberculosis in Indonesia: national trends 2017-19
Iskandar, D., Suwantika, A. A., Pradipta, I. S., Postma, M. J. & van Boven, J. F. M., 3-jan.-2023, In: The Lancet Global Health. 11, 1, blz. 117-125 9 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand1 Citaat (Scopus)63 Downloads (Pure) -
Correction to: "Cost-effectiveness of ACL treatment is dependent on age and activity level: a systematic review"
Deviandri, R., van der Veen, H. C., Lubis, A. M. T., van den Akker-Scheek, I. & Postma, M. J., feb.-2023, In: Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA. 31, 2, blz. 542Onderzoeksoutput: Erratum
Open Access -
Cost-effectiveness of ACL treatment is dependent on age and activity level: a systematic review
Deviandri, R., van der Veen, H. C., Lubis, A. M. T., van den Akker-Scheek, I. & Postma, M. J., feb.-2023, In: Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA. 31, blz. 530–541 12 blz.Onderzoeksoutput: Review article › peer review
Open AccessBestand2 Citaten (Scopus)11 Downloads (Pure) -
Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands
Quist, S. W., Postma, A. J., Myrén, K. J., de Jong, L. A. & Postma, M. J., 2023, In: European Journal of Health Economics. 18 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand22 Downloads (Pure)
-
-
Agora/EURECCA network in oncological precision medicine (Externe Organisatie)
Maarten Postma (Member)
2018Activiteit: Membership › Professional
-
KNMP Najaarscongres 2018
Maarten Postma (Invited speaker)
9-okt.-2018Activiteit: Academic presentation › Academic
-
Scientific Advisory Board KNMP (Externe Organisatie)
Maarten Postma (Member)
2018 → 2019Activiteit: Membership › Professional
-
Datasets
-
Economic analyses of respiratory tract infection diagnostics: a systematic review
van der Pol, S. (Creator), Rojas Garcia, P. (Creator), Postma, M. (Creator), Villar, F. A. (Creator) & van Asselt, T. (Creator), University of Groningen, 16-mei-2021
DOI: 10.5281/zenodo.4765619, https://github.com/UMCG-Global-Health/VALUE-Dx-systematic-review
Dataset
-
Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysis
Zakiyah, N. (Contributor), van Asselt, T. (Contributor) & Postma, M. (Contributor), University of Groningen, 11-nov.-2016
DOI: 10.6084/m9.figshare.4106286.v2
Dataset
-
Budget impact of optimizing rifaximin-α use for the prevention of recurrent hepatic encephalopathy in The Netherlands
de Jong, L. (Contributor), van Schoonhoven, A. (Contributor), Hofstra, H. S. (Contributor), Postma, M. (Contributor) & van Hoek, B. (Contributor), figshare Academic Research System, 9-okt.-2021
DOI: 10.6084/m9.figshare.16779043.v1, https://tandf.figshare.com/articles/dataset/Budget_impact_of_optimizing_rifaximin-_use_for_the_prevention_of_recurrent_hepatic_encephalopathy_in_The_Netherlands/16779043/1
Dataset
-
Ulipristal acetate for pre-operative treatment of moderate to severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysis
van Asselt, T. (Contributor), Postma, M. (Contributor) & Zakiyah, N. (Contributor), University of Groningen, 27-okt.-2016
DOI: 10.6084/m9.figshare.4106286.v1, https://doi.org/10.6084%2Fm9.figshare.4106286.v1
Dataset
-
Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands
Heisen, M. (Contributor), Treur, M. J. (Contributor), Heemstra, H. E. (Contributor), Giesen, E. B. W. (Contributor) & Postma, M. (Contributor), University of Groningen, 19-mei-2017
DOI: 10.6084/m9.figshare.5024366.v1
Dataset
Knipsels
-
Dat meningokokken-vaccin is echt niet te duur, neem het dus op in het programma
15/02/2023
1 Mediabijdrage
Pers / media: Expert Comment › Popular
-
Covid booster jabs: The JCVI advice on coronavirus vaccinations for autumn 2022 and who will get more vaccine
21/05/2022
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
-
Who are the JCVI? -The group advising the government on Covid boosters
30/11/2021
2 items van Media-aandacht
Pers / media: Expert Comment › Popular
-
'Nederland moet meer inzetten op gebruik coronamedicijnen’
04/11/2021
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
-
'Griep is geen grap', zegt Jaap van Dissel. Ook mantelzorgers, familie en zorgverleners van mensen in risicogroep moeten volgens RIVM-directeur griepprik halen
12/10/2021
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
Prijzen
-
-
ISPOR Best Podium Research Presentation Award
Postma, Maarten (Recipient), 2009
Prijs: Prize › Academic